HutchMed to Present Updated Data from Solvleplenib ESLIM-01 Phase III Trial at ASH and ESMO Congress 2024
China-based HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced plans to present new and...
Bayer HealthCare Partners with China Population Welfare Foundation at CIIE for Public Health Initiatives
German pharmaceutical giant Bayer HealthCare (FRA: BAYN) has entered into a partnership agreement with the...
Medtronic Partners with China Resources Guangdong Pharmaceutical at CIIE for Medical Equipment Development
US-Irish firm Medtronic (NYSE: MDT) has entered into a partnership with China-based China Resources Guangdong...
Pfizer’s Talzenna (talazoparib) Approved by China’s NMPA for mCRPC Treatment
The National Medical Products Administration (NMPA) website has indicated that Pfizer’s (NYSE: PFE) marketing filing...
Shouyao Holdings Adjusts Development Strategy for SY-1530, Halts Monotherapy Clinical Trials
Beijing-based Shouyao Holdings (Beijing) Co., Ltd (SHA: 688197) has announced a strategic adjustment regarding its...
Nanjing Leads Biolabs Secures FDA Orphan Drug Designation for LBL-034 in Multiple Myeloma Treatment
Nanjing Leads Biolabs Co., Ltd, a China-based biopharmaceutical company, has announced that it has received...
Sanofi’s Dupixent Gains EMA Approval for Eosinophilic Esophagitis in Children
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced that it has received marketing approval from...
Novartis Forges Partnerships at CIIE to Strengthen Radioligand Therapy Ecosystem in China
At the 7th China International Import Expo (CIIE), Swiss pharmaceutical giant Novartis (NYSE: NVS) announced...
China’s NHC Announces Initiative to Boost Gerontology Medical Services
The National Health Commission (NHC) has issued a notification aimed at enhancing gerontology medical service...
Vantive Secures Collaborations with Kertone and Qiantang Longyue at CIIE for Dialysis Solutions
Vantive, a planned spin-off from U.S.-based Baxter International (NYSE: BAX) specializing in kidney care, has...
Amgen’s Tavneos Receives NMPA Approval for ANCA-Associated Vasculitis Treatment in China
US biotechnology company Amgen (NASDAQ: AMGN) has announced that it has received market approval in...
Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson’s Disease Treatment
US major Boston Scientific Corporation (NYSE: BSX) has officially launched its Vercisie Genius, an implantable...
CARSgen Therapeutics Presents Latest CAR-T Data at ASH Annual Meeting
CARSgen Therapeutics Holdings Ltd (HKG: 2171), a China-based specialist in chimeric antigen receptor (CAR)-T cell...
Changchun High & New Technology Industries Receives NMPA Approval for Long-Acting Somatropin
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661), a leading China-based company, has...
Huadong Medicine Co., Ltd Receives NMPA Approval for Stelara Biosimilar SaiLeXin
Huadong Medicine Co., Ltd (SHE: 000963), a China-based pharmaceutical company, has announced that it has...
Northeast Pharmaceutical to Acquire Majority Stake in Dingcheng Peptide Source for RMB 186.8 Million
China-based Northeast Pharmaceutical Co., Ltd (SHE: 000597) has announced its intention to acquire a 70%...
Ascentage Pharma to Present Olverembatinib and Lisaftoclax Clinical Data at ASH Annual Meeting
China-based Ascentage Pharma (HKG: 6855) has announced that it will present the results of multiple...
CStone Pharmaceuticals Presents CS5001 Clinical Data at the ASH Annual Meeting
China-based CStone Pharmaceuticals (HKG: 2616) has announced the presentation of the latest clinical data on...
Roche to Showcase 40+ Abstracts on Blood Disorders at ASH Annual Meeting
Swiss pharmaceutical giant Roche (SWX: ROG) has announced plans to present over 40 abstracts across...
China Medical System’s Opzelura Approved in Hong Kong for Non-segmental Vitiligo Treatment
China Medical System Holdings (CMS; HKG: 0867) has announced that the market filing for its...